Composition, Method, And Kit For Alpha-1 Proteinase Inhibitor

Patent No. EP2496246 (titled "Composition, Method, And Kit For Alpha-1 Proteinase Inhibitor") was filed by Grifols Therapeutics on Nov 2, 2010. The application was issued on Jun 27, 2018.

Patent Summary

Composition containing alpha 1-proteinase inhibitor (API) and one or more amino acids for stabilizing API-containing pharmaceuticals. The amino acid content is 0.01-3 mM when the composition is exposed to temperatures of 5-40°C for at least 6 months. This stabilized API composition can be useful for treating disorders associated with low API levels like COPD, liver disease, and vascular disorders.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EUROPEAN OPPOSITIONSMar 27, 2019ABTHORPE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2496246

GRIFOLS THERAPEUTICS
Application Number
EP10828979A
Filing Date
Nov 2, 2010
Status
Revoked
May 12, 2023
Publication Date
Jun 27, 2018